University of Wisconsin–Madison

Tau Imaging with MK6240: A Possible Biomarker for AD

This project was led by: Sterling Johnson PhD

This project was funded by: NIH

The term of this project was: May 2017 to June 2020

The number of subjects scanned during this project was: 20

The overall goal of this study is to use the new tau tracer, MK6240, to determine tau burden (neurofibrillary tangles) in Alzheimer’s Disease (AD) vulnerable regions of the brain through PET scanning. This will be accomplished by employing imaging techniques (MRI and PET) and collecting biochemical bio-markers related to AD. Examining this pathology may provide an explanation for the very earliest cognitive changes that occur in AD.